Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Sanofi-Aventis commits 100 million euros to Chinese expansion

April 23, 2009 Research and Development Asia, China, Sanofi-Aventis

France's Sanofi-Aventis is planning a major capital investment programme in Beijing in a bid to bolster its position in the …
News

NICE approves Bayer’s Xarelto

April 23, 2009 Research and Development Bayer, NICE, Xarelto

NICE has approved Bayer's anti-clotting treatment Xarelto, bringing it into line with Boehringer Ingelheim's rival Pradaxa. Xarelto (rivaroxaban) was assessed …
News

Pharma-NHS joint working

April 22, 2009 Research and Development, Sales and Marketing ABPI, doctors, industry relations

An underlying principle for joint working between the NHS and the pharmaceutical industry is that it brings benefits to patients. …
Feature

Little benefit to pharma from G20 initiatives

April 22, 2009 Research and Development, Sales and Marketing Datamonitor, strategy

Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and …
News

AZ shuns mega-mergers but still open to smaller deals

April 21, 2009 Research and Development, Sales and Marketing AZ

AstraZeneca will not follow this year's emerging pharma trend towards mega-mergers and may instead look to smaller-scale deals, according to …
News

Pfizer opens $200m R&D site in St Louis

April 21, 2009 Research and Development Pfizer, US

News

Is the UK falling behind in clinical trials?

April 21, 2009 Research and Development NHS

New initiatives to bolster collaboration between the NHS, academia and industry have come amid claims that the UK is losing …
News

GSK buys Stiefel for $3.6bn

April 20, 2009 Research and Development, Sales and Marketing GSK, MA

GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …
News

GSK and Pfizer to create HIV joint venture company

April 16, 2009 Research and Development, Sales and Marketing GSK, HIV, Pfizer

The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …
News

Merck acquires rights to atrial fibrillation candidate

April 16, 2009 Research and Development, Sales and Marketing Merck, cv

Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …
News

Simponi approved in Canada

April 16, 2009 Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …
News

Covance expands in Latin America

April 15, 2009 Research and Development Covance, Peru, South America

Covance has opened new clinical development offices in Chile and Peru, and expanded its operations in Argentina to help serve …
News

Helsinn chooses Dublin for R&D investment

April 14, 2009 Research and Development Helsinn

Helsinn Birex Pharmaceuticals is to invest 13 million euros in a new pilot-scale R&D facility in Ireland, to help it …
News

Committee approves limited use of Seroquel in depression

April 9, 2009 Research and Development, Sales and Marketing AZ, Seroquel, US

An FDA advisory committee has concluded that safety concerns mean that Seroquel XR should not be used to treat anxiety, …
News

Efient launched in the UK

April 9, 2009 Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025